Annals of Coloproctology

Original Articles

Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program: Dae-Do Park, Rumi Shin, Ji-Sun Kim, Heung-Kwon Oh, Seung-Yong Jeong, Kyu Joo Park, Jae-Gahb Park; J Korean Soc Coloproctol. 2010;26(6):420-423. Published online December 31, 2010; DOI: https://doi.org/10.3393/jksc.2010.26.6.420

2,948 View
24 Download
4 Citations

Purpose

Since 2004, the National Cancer Screening Program of Korea has included colorectal cancer screening based on primary screening with the fecal occult blood test (FOBT). We report on the clinical features of colorectal cancer detected by the National Cancer Screening Program.

Methods

We retrospectively analyzed 577 patients who underwent elective surgery for colorectal cancer at the Seoul National University Hospital between January 2008 and December 2009. We compared the clinical features of colorectal cancers detected by the National Cancer Screening Program (NCSP group) with those of the control group in terms of age, gender, preoperative symptom, location of the tumor, surgical technique and tumor-node-metastasis (TNM) stage.

Results

Age, gender, location of the tumor and operation types were not different between the two groups. The proportion of asymptomatic patients was significantly higher in the NCSP group than it was in the control group (86.5% vs. 20.0%; P < 0.001). The proportion of less invasive lesions (T1 or T2) was significantly higher in the NCSP group (46.3% vs. 27.7%; P = 0.002). The pathologic stages of the colorectal cancers in the NCSP group were I, 40.3%; II, 17.9%; III, 40.3% and IV, 1.5% whereas in the control group, they were I, 20.8%; II, 32.9%; III, 34.9% and IV, 11.4%. The proportion of stage I cancer was significantly higher in the NCSP group than in the control group (40.3% vs. 20.8%; P = 0.006).

Conclusion

Our study demonstrates the FOBT in the NCSP is effective in early detection of colorectal cancer.

Citations

Citations to this article as recorded by

Clinicopathological Characteristics of Colorectal Adenomas and Cancers Detected by FIT-positive Colonoscopy
Seiji Kimura, Shinichiro Yamagishi, Shinsaku Fukuda
Nippon Daicho Komonbyo Gakkai Zasshi.2020; 74(1): 6. CrossRef
Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
Chan Kim, Woo Ram Kim, Ki-Yeol Kim, Hong Jae Chon, Seung Hoon Beom, Hyojoong Kim, Minkyu Jung, Sang Joon Shin, Nam Kyu Kim, Joong Bae Ahn
Clinical Colorectal Cancer.2018; 17(3): e513. CrossRef
Early Colorectal Epithelial Neoplasm in Korea: A Multicenter Survey of Pathologic Diagnosis
Yun Kyung Kang, So-Young Jin, Mee Soo Chang, Jung Yeon Kim, Gyeong Hoon Kang, Hye Seung Lee, Jin Hee Sohn, Ho Sung Park, Kye Won Kwon, Mi Jin Gu, Young Hee Maeng, Jong Eun Joo, Haeng Ji Kang, Hee Kyung Kim, Kee-Taek Jang, Mi Ja Lee, Hee Kyung Chang, Joon
Korean Journal of Pathology.2013; 47(3): 245. CrossRef
Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer
Min Ae Keum, Seok-Byung Lim, Sun A Kim, Yong Sik Yoon, Chan Wook Kim, Chang Sik Yu, Jin Cheon Kim
Journal of the Korean Society of Coloproctology.2012; 28(1): 49. CrossRef

Treatment Patterns for Colorectal Cancer Patients at the National Cancer Center Korea in 2003.: Kim, Duck Woo , Jeong, Seung Yong , Kim, Dae Yong , Sohn, Dae Kyung , Lim, Seok Byung , Chang, Hee Jin , Jung, Kyung Hae , Jeong, Jun Yong , Choi, Hyo Seong , Park, Jae Gahb; J Korean Soc Coloproctol. 2007;23(4):245-249.; DOI: https://doi.org/10.3393/jksc.2007.23.4.245

1,613 View
16 Download
2 Citations

Abstract PDF

PURPOSE
In Korea, colorectal cancer (CRC) is one of the most sharply-increasing malignancies, and the National Colorectal Cancer Screening Program for persons over 50 years of age began in 2004. To determine the effectiveness of the program, comparative data regarding CRCs treated prior to 2004 must be analyzed. The present study assessed CRC status at diagnosis and treatment patterns in 2003.
METHODS
In 2003, 503 patients were newly diagnosed with CRC and were treated at the Center for Colorectal Cancer, National Cancer Center (NCC). Clinical data were retrospectively reviewed.
RESULTS
The 503 patients included 256 colon and 247 rectal cancer patients. Of the 256 colon cancer patients, 5 (2.0%) were diagnosed during screening colonoscopies and were successfully treated using an endoscopic mucosal resection (EMR), and 17 (6.6%) received only palliative chemotherapy because of distant metastases. Forty patients (15.6%) were treated with palliative surgery and chemotherapy, and 194 (75.8%) with curative surgery with or without adjuvant chemotherapy. Of the 247 rectal cancer patients, 9 (3.6%) were treated with an EMR, 20 (8.1%) with palliative chemotherapy with or without radiotherapy, 19 (7.7%) with palliative surgery and chemoradiotherapy, and 199 (80.6%) with curative surgery with or without chemoradiotherapy. Treatment with curative intent was possible in 199 of 256 (77.7%) colon cancer patients and in 208 of 247 (84.2%) rectal cancer patients.
CONCLUSIONS
Only 12.1% of colon and 8.5% of rectal cancer patients were diagnosed early and treated without adjuvant therapies at the NCC in Korea in 2003.

Citations

Citations to this article as recorded by

Lymphovascular Invasion is a Significant Prognosticator in Rectal Cancer Patients Who Receive Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision
Jong Hoon Lee, Hong Seok Jang, Jun-Gi Kim, Hyun Min Cho, Byoung Yong Shim, Seong Taek Oh, Sei-Chul Yoon, Yeon-Sil Kim, Byung Ock Choi, Sung Hwan Kim
Annals of Surgical Oncology.2012; 19(4): 1213. CrossRef
Role of Radiation Therapy as an Adjuvant Treatment in Rectal Cancer Management
Jae Hwan Oh, Dae Yong Kim
Journal of the Korean Society of Coloproctology.2009; 25(4): 273. CrossRef

First
Prev
Page of 1
Next
Last

Search